Cabergoline
- PDF / 168,884 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 103 Downloads / 141 Views
1 S
Impulse control disorder: case report A cross sectional study conducted between 2016 and 2019 described a male patient [age not stated], who developed impulse control disorder (ICD) during treatment with cabergoline [indication, route, dosage and duration of treatment to reaction onset not stated]. The male patient, who had been receiving cabergoline was admitted in Turkey for the unspecified underlying condition. Subsequently, he developed ICD, which was later resolved. Ozkaya HM, et al. Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas. Growth 803514666 Hormone and IGF Research 55: 101356, Dec 2020. Available from: URL: http://doi.org/10.1016/j.ghir.2020.101356
0114-9954/20/1830-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 14 Nov 2020 No. 1830
Data Loading...
